Lorena Sanchez-Felipe (Lorena Sanchez Felipe)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Papillary Thyroid

Immune Response

Top Venues

European journal of immunology

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Lorena Sanchez-Felipe, Yeranddy A Alpizar, Ji Ma, Lotte Coelmont, Kai Dallmeier
YF17D-based vaccines - standing on the shoulders of a giant. European journal of immunology (2024)
Lorena Sanchez-Felipe, Yeranddy A Alpizar, Ji Ma, Lotte Coelmont, Kai Dallmeier
YF17D-based vaccines - standing on the shoulders of a giant. European journal of immunology 54 (5) (2024)
Lorena Sanchez-Felipe, Yeranddy A Alpizar, Ji Ma, Lotte Coelmont, Kai Dallmeier
YF17D-based vaccines - standing on the shoulders of a giant. European journal of immunology 54 (5) (2024)
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, Winston Chiu, Thomas Vercruysse, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Lorena Sanchez-Felipe, Kai Dallmeier
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge. NPJ vaccines 8 (1) (2023)
Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe, Niraj Mishra, Thomas Vercruysse, Dieudonné Buh Kum, Hendrik-Jan Thibaut, Johan Neyts, Kai Dallmeier
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice. Emerging microbes & infections 10 (1) (2022)
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, Winnie Kerstens, Madina Rasulova, Lindsey Bervoets, Carolien De Keyzer, Rana Abdelnabi, Shi-Yan Caroline Foo, Viktor Lemmens, Dominique Van Looveren, Piet Maes, Guy Baele, Birgit Weynand, Philippe Lemey, Johan Neyts, Hendrik-Jan Thibaut, Kai Dallmeier
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters. Nature communications 13 (1) (2022)
Sapna Sharma, Michael Alexander Schmid, Lorena Sanchez-Felipe, Jana Grenelle, Suzanne J F Kaptein, Lotte Coelmont, Johan Neyts, Kai Dallmeier
Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Human vaccines & immunotherapeutics 16 (9) (2020)
Lorena Sanchez-Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Dominique Van Looveren, Mahadesh Prasad Arkalagud Javarappa, Robbert Boudewijns, Bert Malengier-Devlies, Laurens Liesenborghs, Suzanne J F Kaptein, Carolien De Keyzer, Lindsey Bervoets, Sarah Debaveye, Madina Rasulova, Laura Seldeslachts, Li-Hsin Li, Sander Jansen, Michael Bright Yakass, Babs E Verstrepen, Kinga P Böszörményi, Gwendoline Kiemenyi-Kayere, Nikki van Driel, Osbourne Quaye, Xin Zhang, Sebastiaan Ter Horst, Niraj Mishra, Ward Deboutte, Jelle Matthijnssens, Lotte Coelmont, Corinne Vandermeulen, Elisabeth Heylen, Valentijn Vergote, Dominique Schols, Zhongde Wang, Willy M J M Bogers, Thijs Kuiken, Ernst J Verschoor, Christopher J Cawthorne, Koen Van Laere, Ghislain Opdenakker, Greetje Vande Velde, Birgit Weynand, Dirk E Teuwen, Patrick Matthys, Johan Neyts, Hendrik-Jan Thibaut, Kai Dallmeier
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature 590 (7845) (2020)